$VOR Balance Sheet | Understand Stock

$VOR

$19.54 +$1.21 (6.6%) Close

$VOR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Investments
Restricted cash equivalents
Marketable securities
Prepaid expenses
Other current assets
Total current assets

Restricted cash
Property and equipment, net
Operating lease right-of-use assets
Other assets
Total assets
Liabilities and stockholders' equity (deficit)
Current liabilities:
Accounts payable
Accrued liabilities
Operating lease liabilities
Other current liabilities
Total current liabilities
Non-current liabilities:
Operating lease liabilities, less current portion
Warrant liabilities
Total liabilities
Stockholders' deficit:
Common stock, $0.0001 par value; 800,000,000 and 400,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 54,455,751 and 38,720,196 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated deficit
Total stockholders' deficit
Total liabilities and stockholders' deficit

Comments